308 related articles for article (PubMed ID: 31169138)
1. Pretreatment elevated fibrinogen level predicts worse oncologic outcomes in upper tract urothelial carcinoma.
Xu H; Ai JZ; Tan P; Lin TH; Jin X; Gong LN; Lei HR; Yang L; Wei Q
Asian J Androl; 2020; 22(2):177-183. PubMed ID: 31169138
[TBL] [Abstract][Full Text] [Related]
2. The preoperative serum cystatin-C as an independent prognostic factor for survival in upper tract urothelial carcinoma.
Tan P; Shi M; Chen J; Xu H; Xie N; Xu H; Jiang Y; Ai JZ; Liu LR; Yang L; Wei Q
Asian J Androl; 2019; 21(2):163-169. PubMed ID: 30416134
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Plasma Fibrinogen Level Represents an Independent Prognostic Factor in a Chinese Cohort of Patients with Upper Tract Urothelial Carcinoma.
Zhang B; Song Y; Jin J; Zhou LQ; He ZS; Shen C; He Q; Li J; Liu LB; Wang C; Chen XY; Fan Y; Hu S; Zhang L; Yu W; Han WK
PLoS One; 2016; 11(3):e0150193. PubMed ID: 26930207
[TBL] [Abstract][Full Text] [Related]
5. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
Chung HS; Hwang EC; Kim MS; Yu SH; Jung SI; Kang TW; Choi C; Choi SH; Kwon TG; Noh JH; Kim MK; Cho WJ; Kang SG; Kang SH; Cheon J; Seo IY; Chung H; Kim HS; Lee CH; Ku JY; Ha HK; Kim BH; Jeong CW; Ku JH; Kwak C; Kwon D
Clin Genitourin Cancer; 2019 Jun; 17(3):e394-e407. PubMed ID: 30782419
[TBL] [Abstract][Full Text] [Related]
6. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
Shibing Y; Turun S; Qiang W; Junhao L; Haichao Y; Shengqiang Q; Ping H; Dehong C
Urol Oncol; 2015 May; 33(5):204.e9-16. PubMed ID: 25800374
[TBL] [Abstract][Full Text] [Related]
7. Association between lymphovascular invasion and oncologic outcomes among upper urinary tract urothelial carcinoma patients who underwent radical nephroureterectomy.
Song SH; Ye CH; Lee S; Hong SK; Byun SS; Lee SE; Oh JJ
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2863-2870. PubMed ID: 31501983
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
9. Validation of the preoperative controlling nutritional status score as an independent predictor in a large Chinese cohort of patients with upper tract urothelial carcinoma.
Xu H; Tan P; Jin X; Ai J; Lin T; Lei H; Yang L; Wei Q
Cancer Med; 2018 Dec; 7(12):6112-6123. PubMed ID: 30485712
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M
BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942
[TBL] [Abstract][Full Text] [Related]
11. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
Fritsche HM; Novara G; Burger M; Gupta A; Matsumoto K; Kassouf W; Sircar K; Zattoni F; Walton T; Tritschler S; Baba S; Bastian PJ; Martínez-Salamanca JI; Seitz C; Otto W; Wieland WF; Karakiewicz PI; Ficarra V; Hartmann A; Shariat SF
Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
[TBL] [Abstract][Full Text] [Related]
13. Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy.
Liu W; Wang Z; Liu S; Yao Y; Liu Y; Zhang G
BMC Cancer; 2020 Nov; 20(1):1113. PubMed ID: 33198698
[TBL] [Abstract][Full Text] [Related]
14. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
[TBL] [Abstract][Full Text] [Related]
15. Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma.
Singla N; Krabbe LM; Aydin AM; Panwar V; Woldu SL; Freifeld Y; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Sagalowsky AI; Shariat SF; Lotan Y; Bagrodia A; Kapur P; Margulis V
Urol Oncol; 2018 Jul; 36(7):343.e1-343.e8. PubMed ID: 29748098
[TBL] [Abstract][Full Text] [Related]
16. Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma.
Foerster B; Moschini M; Abufaraj M; Soria F; Gust KM; Rouprêt M; Karakiewicz PI; Briganti A; Rink M; Kluth L; Mathieu R; Margulis V; Lotan Y; Aziz A; John H; Shariat SF;
Clin Genitourin Cancer; 2017 Dec; 15(6):e1039-e1045. PubMed ID: 28694147
[TBL] [Abstract][Full Text] [Related]
17. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Miyazaki Y; Kobayashi H; Kaneko G; Hagiwara M; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Hara S; Oyama M; Momma T; Nakajima Y; Jinzaki M; Oya M
Ann Surg Oncol; 2014 Nov; 21(12):4041-8. PubMed ID: 24912614
[TBL] [Abstract][Full Text] [Related]
18. Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.
Kido K; Hatakeyama S; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Iwabuchi I; Ogasawara M; Kawaguchi T; Ohyama C
Int J Clin Oncol; 2018 Aug; 23(4):726-733. PubMed ID: 29435873
[TBL] [Abstract][Full Text] [Related]
19. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
Vartolomei MD; Mathieu R; Margulis V; Karam JA; Rouprêt M; Lucca I; Mbeutcha A; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Rioux-Leclercq N; Haitel A; Bensalah K; Rink M; Briganti A; Xylinas E; Shariat SF
World J Urol; 2017 Jan; 35(1):121-130. PubMed ID: 27209168
[TBL] [Abstract][Full Text] [Related]
20. Is preoperative serum lactate dehydrogenase useful in predicting the outcomes of patients with upper tract urothelial carcinoma?
Tan P; Chen J; Xie N; Xu H; Ai J; Xu H; Liu L; Yang L; Wei Q
Cancer Med; 2018 Oct; 7(10):5096-5106. PubMed ID: 30151961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]